PROBLEMATIC ISSUES IN THE EVALUATION OF MOLECULAR CHARACTERISTICS AND POTENTIAL NEOPLASTIC TRANSFORMATION OF CERVICAL METAPLASIA
Keywords:Metaplasia, Neoplastic transformation, Endocervix
Metaplasia represents the replacement of one differentiated cell type with another differentiated cell type, which is frequently seen in uterine cervix, particularly in endocervical epithelium. There are many different types of metaplasia in endocervix. It is suggested that metaplasia represents the fertile soil for the development of neoplasia. However, which cases of metaplasia transform into neoplasia, which type of metaplasia is more realted to neoplastic transformation or if there are some molecular markers which can predict the potential of neoplastic transformation, are nowadays less known. Current review represents the critical discussion of the available literature with regards to the evaluation of molecular markers and the potential of neoplastic transformation in cervical metaplasia.
Veronique Giroux and Anil K. Rustgi, “Metaplasia: tissue injury adaptation and a precursor to the dysplasia–cancer sequence,” Physiol. Behav., vol. 176, no. 1, pp. 139–148, 2018.
L. Y. Hwang, Y. Ma, S. C. Shiboski, S. Farhat, J. Jonte, and A.-B. Moscicki, “Active squamous metaplasia of the cervical epithelium is associated with subsequent acquisition of human papillomavirus 16 infection among healthy young women.,” J. Infect. Dis., vol. 206, no. 4, pp. 504–511, Aug. 2012.
S. A. Hong, S. H. Yoo, J. Choi, S. J. Robboy, and K. R. Kim, “A review and update on papillary immature metaplasia of the uterine cervix: A distinct subset of low-grade squamous intraepithelial lesion, proposing a possible cell of origin,” Arch. Pathol. Lab. Med., vol. 142, no. 8, pp. 973–981, 2018.
D. Mockler, L. F. Escobar-hoyos, A. Akalin, J. Romeiser, A. L. Shroyer, and K. R. Shroyer, “Keratin 17 Is a Prognostic Biomarker in Endocervical Glandular Neoplasia,” vol. 17, 2017.
D. C. Wilbur, “Practical issues related to uterine pathology: in situ and invasive cervical glandular lesions and their benign mimics: emphasis on cytology–histology correlation and interpretive pitfalls,” Mod. Pathol., vol. 29, no. 1, pp. S1–S11, 2016.
J. Loureiro and E. Oliva, “The spectrum of cervical glandular neoplasia and issues in differential diagnosis,” Arch. Pathol. Lab. Med., vol. 138, no. 4, pp. 453–483, 2014.
A. M. El-Saka, Y. A. Zamzam, Y. A. Zamzam, and A. El-Dorf, “Could Obesity be a Triggering Factor for Endometrial Tubal Metaplasia to be a Precancerous Lesion?,” J. Obes., vol. 2020, p. 2825905, 2020.
X. Sun and P. D. Kaufman, “Ki-67: more than a proliferation marker,” Chromosoma, vol. 127, no. 2, pp. 175–186, Jun. 2018.
K. L. Talia and W. G. McCluggage, “The developing spectrum of gastric-type cervical glandular lesions.,” Pathology, vol. 50, no. 2, pp. 122–133, Feb. 2018.
F. Ɨ Ferreira, M. Ɨ Ferreira, C. Fialho, and T. Amaro, “Transitional Metaplasia in Cervical Smears : A Case Report,” 2016.
A. A. Nkili-Meyong et al., “Genome-wide profiling of human papillomavirus DNA integration in liquid-based cytology specimens from a Gabonese female population using HPV capture technology.,” Sci. Rep., vol. 9, no. 1, p. 1504, Feb. 2019.
J. Doorbar and H. Griffin, “Refining our understanding of cervical neoplasia and its cellular origins,” Papillomavirus Res., vol. 7, no. March, pp. 176–179, 2019.
A. Hebbar and V. S. Murthy, “Role of p16/INK4a and Ki-67 as specific biomarkers for cervical intraepithelial neoplasia: An institutional study,” J. Lab. Physicians, vol. 9, no. 2, pp. 104–110, 2017.
S. Regauer and O. Reich, “CK17 and p16 expression patterns distinguish (atypical) immature squamous metaplasia from high-grade cervical intraepithelial neoplasia (CIN III),” Histopathology, vol. 50, no. 5, pp. 629–635, Apr. 2007.
M. S. D’Arcy, “Cell death: a review of the major forms of apoptosis, necrosis and autophagy.,” Cell Biol. Int., vol. 43, no. 6, pp. 582–592, Jun. 2019.
M. Shimada, A. Yamashita, M. Saito, M. Ichino, and T. Kinjo, “The human papillomavirus E6 protein targets apoptosis ‑ inducing factor ( AIF ) for degradation,” Sci. Rep., pp. 1–14, 2020.
V. Aparecida and É. De Brito, “www.ssoar.info Factors associated to uterine-cervix changes in women assisted in a pole town in western Santa Catarina,” 2017.
E. Lerma et al., “Prognostic significance of the Fas-receptor/Fas-ligand system in cervical squamous cell carcinoma.,” Virchows Arch., vol. 452, no. 1, pp. 65–74, Jan. 2008.
V. Suvarna, V. Singh, and M. Murahari, “Current overview on the clinical update of Bcl-2 anti-apoptotic inhibitors for cancer therapy.,” Eur. J. Pharmacol., vol. 862, p. 172655, Nov. 2019.
M. C. M. Guimarães, M. A. G. Gonçalves, C. P. Soares, J. S. R. Bettini, R. A. Duarte, and E. G. Soares, “Immunohistochemical expression of p16INK4a and bcl-2 according to HPV type and to the progression of cervical squamous intraepithelial lesions.,” J. Histochem. Cytochem. Off. J. Histochem. Soc., vol. 53, no. 4, pp. 509–516, Apr. 2005.
B. O. W. Kim et al., “Bcl-2-like Protein 11 ( BIM ) Expression Is Associated with Favorable Prognosis for Patients with Cervical Cancer,” vol. 4879, pp. 4873–4879, 2017.
R. I. Cameron, P. Maxwell, D. Jenkins, and W. G. McCluggage, “Immunohistochemical staining with MIB1, bcl2 and p16 assists in the distinction of cervical glandular intraepithelial neoplasia from tubo-endometrial metaplasia, endometriosis and microglandular hyperplasia.,” Histopathology, vol. 41, no. 4, pp. 313–321, Oct. 2002.
B. Ramachandran, “Functional association of oestrogen receptors with HPV infection in cervical carcinogenesis,” Endocr. Relat. Cancer, vol. 24, no. 4, pp. R99–R108, 2017.